(Q34660553)

English

Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial

scientific article published on August 4, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-acting injectable vs quetiapine: results of a long-term, open-label, randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

schizoaffective disorder

1 reference

based on heuristic

inferred from title

relapse prevention

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Enrico Smeraldi

8

object named as

Enrico Smeraldi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Wolfgang Gaebel

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Andreas Schreiner

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Paul Bergmans

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Rosario de Arce

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Frédéric Rouillon

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Joachim Cordes

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lars Eriksson

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

4 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

full work available at URL

https://www.nature.com/articles/npp2010111.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20686456/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20686456/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

https://europepmc.org/articles/PMC3055334

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

https://europepmc.org/articles/PMC3055334?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

https://doi.org/10.1038/npp.2010.111

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20686456

17 June 2024

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2367-2377

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Hyperprolactinemia associated with psychotropics--a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

A review of the safety and tolerability of aripiprazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Partial compliance in schizophrenia and the impact on patient outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Olanzapine pamoate: a stick in time? A review of the efficacy and safety profile of a new depot formulation of a second-generation antipsychotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Quetiapine: dose-response relationship in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Treatment adherence and long-term outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Cognitive functioning and acute sedative effects of risperidone and quetiapine in patients with stable bipolar I disorder: a randomized, double-blind, crossover study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Utilization of long-acting antipsychotic medication in patient care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Relapse and rehospitalization: comparing oral and depot antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Antipsychotic medication adherence: is there a difference between typical and atypical agents?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

7 July 2018

Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

What does the PANSS mean?

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

The differentiation between 'lack of insight' and 'dysfunctional health beliefs' in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Somnolence effects of antipsychotic medications and the risk of unintentional injury

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2010.111

21 January 2018

Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3055334

26 October 2018

Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20686456

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NPP.2010.111

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34660553&oldid=2196922601"